3/18/2025 3:21 PM
Sarepta Therapeutics Inc (NASDAQ:SRPT) is down 23.2% to trade at $77.86 at last check, and earlier hit a 52-week low of $75.06. The security is pacing for its worst single-day percentage loss since Oc...
1/10/2025 11:30 AM
Beam Therapeutics (BEAM) Gene editing firm Beam Therapeutics is developing its own pipeline with base editing as
its foundation technology, a technique that changes a single DNA or RNA base without
c...
12/27/2023 3:36 PM
Subscribers to Chart of the Week received this commentary on Sunday, December 24. Taylor Swift may have won Time Person of the Year, but in the investing world, artificial intelligence (AI) was the ...
7/18/2022 1:15 AM
There are short-term and long-term opportunities for PFE stock Pfizer ( NYSE: PFE ) stock is down 12% in 2022. Even though that’s better than the broader market, there are some concerns that Pfiz...